Medication adherence and healthcare disparities: impact of statin co-payment reduction.

Predicting adherence trajectory using initial patterns of medication filling.

Selective serotonin reuptake inhibitor use and perioperative bleeding and mortality in patients undergoing coronary artery bypass grafting: a cohort study.

Rationale and design of the Randomized Evaluation to Measure Improvements in Non-adherence from Low-Cost Devices (REMIND) trial.

Patient Use of Email, Facebook, and Physician Websites to Communicate with Physicians: A National Online Survey of Retail Pharmacy Users.

Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study.

Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction.

Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning.

Association between trajectories of statin adherence and subsequent cardiovascular events.

Observing versus predicting: Initial patterns of filling predict long-term adherence more accurately than high-dimensional modeling techniques.

Cost-effectiveness of novel regimens for the treatment of Hepatitis C Virus.

Paying physicians to prescribe generic drugs and follow-on biologics in the United States.

Availability and utilization of cardiovascular fixed-dose combination drugs in the United States.

A unified framework for classification of methods for benefit-risk assessment.

Prescription drug insurance coverage and patient health outcomes: a systematic review.

Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.

Cigarette purchases at pharmacies by patients at high risk of smoking-related illness.

Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD.

Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels.

Pharmacy-based interventions to reduce primary medication nonadherence to cardiovascular medications.

Selecting a specialist: Adding evidence to the clinical practice of making referrals.

Patients' preferences in anticoagulant therapy: discrete choice experiment.

Patterns of initiation of oral anticoagulants in patients with atrial fibrillation- quality and cost implications.

Quality of care at retail clinics for 3 common conditions.

A cross-national comparison of 17 countries' insulin glargine drug labels.

Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study.

Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: Cohort and nested case–control studies.

Did HEDIS get it right? Evaluating the quality of a quality measure: Adherence to β-blockers and cardiovascular outcomes after myocardial infarction.

Equity in the receipt of oseltamivir in the United States during the H1N1 pandemic.

Eliminating medication copayments reduces disparities in cardiovascular care.